The rate of NF1 mutations is comparable to that of cutaneous melanoma (~14%); however, BRAF/NRAS mutations rates are remarkably lower, and KIT mutations are observed in at least 13% of cases [35,43,44]. Here, NRAS is linked to cutaneous melanoma.